Auricular Point Acupressure to Manage Chemotherapy Induced Neuropathy

Completed · Not applicable

Conditions studied: Chemotherapy-induced Neuropathy

In brief

The proposed randomized control trial will evaluate auricular point acupressure (APA) on chemotherapy-induced neuropathy (CIN), rigorously considering point specificity and placebo effects by integrating self-report measures, psychophysical measures (QST), endogenous biomarkers (cytokines), and neuro-imaging to investigate APA's efficacy and underlying mechanism(s).

Key facts

Study ID
NCT04920097
Run by
The University of Texas Health Science Center, Houston
People needed
238
Starts
2021-07-08
Expected to finish
2026-03-19
Last updated by the study team
2026-08-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.